Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Advanced Medical Solutions ( (GB:AMS) ) has provided an announcement.
Advanced Medical Solutions Group plc has announced its total issued share capital as of January 31, 2025, comprising 217,866,661 ordinary shares with voting rights, in compliance with the FCA’s Disclosure and Transparency Rules. This information is essential for shareholders to calculate their notification requirements regarding their interests in the company, reflecting AMS’s commitment to regulatory transparency and effective stakeholder communication.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer specializing in innovative tissue-healing technologies. The company markets a diverse range of surgical products, including tissue adhesives, sutures, haemostats, and sealants, aimed at enhancing patient outcomes and providing value for healthcare payers. AMS operates globally with products manufactured across multiple countries and a strong presence in R&D through innovation hubs located in the UK, Ireland, Germany, France, and Israel.
YTD Price Performance: 7.54%
Average Trading Volume: 418,998
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £455.5M
See more insights into AMS stock on TipRanks’ Stock Analysis page.
